Bluesphere Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$239K Buy
1,987
+3
+0.2% +$346 0.09% 106
2025
Q4
$209K Buy
+1,984
New +$186K 0.09% 94
2025
Q1
Sell
-4,170
Closed -$415K 103
2024
Q4
$415K Sell
4,170
-12
-0.3% -$1.24K 0.2% 62
2024
Q3
$475K Sell
4,182
-534
-11% -$63.4K 0.23% 56
2024
Q2
$584K Buy
4,716
+1,079
+30% +$139K 0.3% 42
2024
Q1
$480K Buy
3,637
+2
+0.1% +$247 0.27% 54
2023
Q4
$396K Buy
3,635
+2
+0.1% +$208 0.25% 58
2023
Q3
$374K Buy
3,633
+2
+0.1% +$216 0.27% 48
2023
Q2
$419K Buy
3,631
+2
+0.1% +$227 0.29% 49
2023
Q1
$386K Buy
3,629
+1
+0% +$108 0.32% 54
2022
Q4
$402K Buy
3,628
+2
+0.1% +$204 0.36% 48
2022
Q3
$312K Buy
3,626
+142
+4% +$12.7K 0.31% 51
2022
Q2
$318K Buy
3,484
+80
+2% +$7.09K 0.31% 55
2022
Q1
$279K Hold
3,404
0.24% 74
2021
Q4
$261K Hold
3,404
0.22% 79
2021
Q3
$256K Buy
3,404
+371
+12% +$28.2K 0.25% 70
2021
Q2
$236K Sell
3,033
-243
-7% -$18.1K 0.21% 79
2021
Q1
$241K Buy
+3,276
New +$242K 0.22% 82

Other funds holding MRK

Bluesphere Advisors's MRK Position: Q1 2026 in Review

Bluesphere Advisors increased its Merck (MRK) stake by 0.15% in Q1 2026, buying an estimated $346 and bringing the position to 1,987 shares worth $239K. The position accounts for 0.09% of the portfolio, ranked #106.

Bluesphere Advisors first reported a position in MRK in Q1 2021 and has held it in 18 quarters since. The position peaked at $584K in Q2 2024. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Bluesphere Advisors held 1,987 shares of Merck worth $239K as of Q1 2026.
  • Bluesphere Advisors bought 3 Merck shares in Q1 2026, an estimated $346.
  • Merck made up 0.09% of Bluesphere Advisors's portfolio in Q1 2026, its #106 holding.
  • Bluesphere Advisors first reported a position in Merck in Q1 2021 and has held it in 18 quarters since.
  • Bluesphere Advisors's Merck position peaked at $584K in Q2 2024.
  • 3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Bluesphere Advisors's 13F filing for Q1 2026, filed 22 Apr 2026.